Luca Castagna

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Blood · 2011 · 311 citations · Full text

Medicine, Hematology, Oncology +16

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani et al. · Blood · 2017 · 236 citations · Full text

Medicine, Hematology, Immunology +16

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

Armando Santoro, Massimo Magagnoli, Michele Spina et al. · Haematologica · 2007 · 235 citations · Full text

Medicine, Oncology, Pharmacology +16

Resilience in multilayer networks

Piet Demeester, Michaël Gryseels, Achim Autenrieth et al. · IEEE Communications Magazine · 1999 · 200 citations

Computing, Systems Engineering, Computer Networks +16

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Corrado Girmenia, Gian María Rossolini, Alfonso Piciocchi et al. · Bone Marrow Transplantation · 2014 · 188 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14